{"result": {"id": "6d5ac541-ac70-4fad-a509-4e24885fabf3", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>MRA<|>ORGANIZATION<|>MRA is a type of medication used for treating conditions like primary aldosteronism, with potential side effects such as male gynecomastia and sexual dysfunction\")\n##\n(\"entity\"<|>PRA<|>ORGANIZATION<|>PRA is a measurement used to assess the effectiveness of MRA treatment in patients\")\n##\n(\"entity\"<|>CCB<|>ORGANIZATION<|>CCB is a class of antihypertensive drugs used when MRA alone is insufficient for blood pressure control\")\n##\n(\"entity\"<|>ACEI<|>ORGANIZATION<|>ACEI is a class of antihypertensive drugs used in combination with MRA for better blood pressure management\")\n##\n(\"entity\"<|>ARB<|>ORGANIZATION<|>ARB is a class of antihypertensive drugs used alongside MRA for treating hypertension\")\n##\n(\"entity\"<|>ARNI<|>ORGANIZATION<|>ARNI is a class of antihypertensive drugs used in combination with other medications for blood pressure control\")\n##\n(\"entity\"<|>GRA<|>ORGANIZATION<|>GRA is a type of familial hyperaldosteronism that can be treated with low-dose dexamethasone\")\n##\n(\"entity\"<|>PCC<|>ORGANIZATION<|>PCC is a neuroendocrine tumor originating from the adrenal medulla, capable of secreting catecholamines\")\n##\n(\"entity\"<|>PGL<|>ORGANIZATION<|>PGL is a neuroendocrine tumor from the sympathetic chain, often associated with PCC\")\n##\n(\"entity\"<|>PPGL<|>ORGANIZATION<|>PPGL is the combined term for PCC and PGL, tumors that can secrete catecholamines\")\n##\n(\"entity\"<|>HNPGL<|>ORGANIZATION<|>HNPGL is a type of PGL located in the head and neck region, not producing catecholamines\")\n##\n(\"relationship\"<|>MRA<|>PRA<|>PRA levels are used to monitor the effectiveness of MRA treatment<|>7)\n##\n(\"relationship\"<|>MRA<|>CCB<|>CCB can be added to MRA for better blood pressure control<|>6)\n##\n(\"relationship\"<|>MRA<|>ACEI<|>ACEI can be combined with MRA to manage hypertension<|>6)\n##\n(\"relationship\"<|>MRA<|>ARB<|>ARB is used alongside MRA for treating high blood pressure<|>6)\n##\n(\"relationship\"<|>MRA<|>ARNI<|>ARNI is another class of drugs that can be combined with MRA<|>6)\n##\n(\"relationship\"<|>PCC<|>PGL<|>PCC and PGL are often grouped together as PPGL due to their similar characteristics<|>8)\n##\n(\"relationship\"<|>PPGL<|>HNPGL<|>HNPGL is a subtype of PGL, which is part of PPGL<|>7)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558788, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 694, "prompt_tokens": 2533, "total_tokens": 3227, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 741}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: �内酯 ,eGFR<30mL/(min ·1.73m2) 者应 禁 用 。 使 用 MRA 治 疗 的 患 者 , 如 果 PRA> 1 μg/(L ·h) ,则提示患者心血管事件发生率和死亡 率等同于原发性高血压患者 , 药物治疗有效[721] 。螺 内酯的主要不良反应为男性乳房发育、性功能降低和 女性月经 紊 乱 , 对 于 不 耐 受 者 , 可 以 使 用 高 选 择 性 MRA,如依普利酮 。新型的非甾体类 MRA,如非奈利 酮 ,对原发性醛固酮增多症的疗效值得验证 。对于单 一使用 MRA无法控制血压者 ,应考虑加用其他类别 的降压药 。 比较常用的有 CCB、ACEI、ARB、ARNI和 非保钾利尿剂 。使用期间应注意监测电解质和肾功 能 。对于 GRA患者可以使用小剂量地塞米松进行治 疗 ,其余类型的家族性醛固酮增多症患者使用 MRA 治疗 。近年 , 国内外临床试验表明经皮肾上腺消融治 疗原发性醛固酮增多症安全有效 ,不良反应少 ,对不适 合手术治疗和对药物干预疗效不佳的原发性醛固酮增 多症患者是一种治疗选择[722-723] 。\n10.6   嗜铬细胞瘤和副神经节瘤\n　10.6.1   定义、患病率及遗传学机制    嗜铬细胞瘤 (pheochromocytoma,PCC) 起源于肾上腺髓质 , 副神 经节瘤(paraganglioma, PGL) 来自胸、腹和盆腔脊椎 旁交感神经链 ,为神经内分泌肿瘤 ,合称嗜铬细胞瘤及 副神经节瘤(pheochromocytoma and paraganglioma,\n\n\n\n　PPGL) 。肿瘤可分泌大量儿茶酚胺 , 即去甲肾上腺  素、肾上腺素和多巴胺 。沿颈部和颅底分布的来自舌  咽、迷走神经的头颈部 PGL(head and neck paragan- glioma,HNPGL) 不产生儿茶酚胺[724-725] 。在非嗜铬  组织或其他软组织出现转移病灶不再称恶性 ,而命名  为转移性 PPGL;按肿瘤定位、原发肿瘤和有无转移分  为 TNM(tumor, node, metastasis) Ⅰ ~ Ⅳ期[726] 。\n　　　PPGL患病率 :普通高血压门诊 0.2% ~ 0.6%、 儿童高血压 1.7%、肾上腺意外瘤中 5% ; 其中 PCC 80%~85%、PGL 15%~ 20% 。遗传性 35%~ 40% ;  转移性 10%~ 17% ,其中 PCC 5% ~ 20% ,交感神经  性 PGL 15% ~ 35% 。发病高峰 30~ 50岁 , 无性别  差异。\n　　　约 50%的 PPGL 患 者 有 致 病 基 因 突 变 , 其 中 35%~40%为胚系突变 ,15%~25%为肿瘤体系突变 ; 50%~70%的儿童为胚系突变。\n　　　43% ~\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_ff318b5b7cf1521e88f4ca57ef9a32e61ab4b63d82ca82af361a54eff110dde1_v2"}